Individualized Cadence Thresholds for Moderate-to-Vigorous Intensity in Obese Taiwanese Young Adults
NCT ID: NCT06883253
Last Updated: 2025-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
48 participants
OBSERVATIONAL
2017-11-15
2018-11-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aquatic_Training in Obese Women
NCT06371105
Cadence and Intensity Across the Adult Lifespan
NCT02650258
Comparison of Different Exercise Trainings on Heart Rate Variability
NCT05215275
The Effectiveness of Lifestyle Intervention on Body Composition, Physical Performances and Quality of Life Among Elderly People in Long-term Care Facilities
NCT02912338
Effects of Different Exercises on Energy Metabolism and Muscle Activation in Normal-Weight and Overweight Students
NCT07147985
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: This study recruited 48 obese young adults who did not regularly engage in exercise. Exclusion criteria included a history of smoking, hypertension, diabetes, cardiovascular or respiratory diseases, neuromuscular or musculoskeletal disorders, or any condition deemed unsuitable for exercise by a physician. The study protocol was approved by the Fu Jen University Institutional Review Board for Human Research (Approval Number: C105137). All participants were fully informed about the study procedures and provided written informed consent prior to participation.
Anthropometrics and Body Composition Measurements Participants arrived at the lab fasted for a minimum of 3 hours, abstained from exercise for 12 hours, avoided caffeine for 6 hours, and refrained from alcohol consumption for 12 hours. Data collection for each subject occurred during the morning hours, as close as possible to awakening from sleep (i.e., from 7:00 AM to 10:00 AM). Height was measured using a digital stadiometer accuracy nearest to ± 0.1 cm (Kongho-Super View, Kong Ho Instruments Co., Ltd., New Taipei, Taiwan). Body composition was assessed using bioelectrical impedance analysis (BIA) with the InBody 720 device (Biospace Co., Ltd., Seoul, South Korea). Skin resistance was measured through an eight-point tactile-electrode system at different frequencies (1 kHz, 5 kHz, 50 kHz, 250 kHz, 500 kHz, 1 MHz). Lean body mass and fat mass were determined from the impedance values using the manufacturer's regression equations, based on the principle that different tissues have varying water content and, consequently, different electrical conductivity 30. The components used in further analysis included weight, body mass index (BMI), body fat mass (BFM), body fat percentage (FAT), visceral fat area (VFA), and skeletal muscle mass (SMM).
Incremental Submaximal Exercise Testing Protocol Participants were instructed to refrain from vigorous exercise, smoking, and the consumption of caffeine-containing foods and beverages for 24 hours prior to the experiment. During the test, each participant was equipped with a gas analyzer (MetaMax 3B, Cortex, Leipzig, Germany) and a heart rate monitor (Polar H10, Electro Oy, Kempele, Finland). The protocol began with a 10-minute seated rest period to measure resting oxygen consumption. Subsequently, participants completed an incremental submaximal treadmill walking test consisting of five stages, with speeds set at 3.2, 4.0, 4.8, 5.6, and 6.4 km/h. Each stage lasted 5 minutes, and participants were instructed to maintain a natural walking pattern throughout the test. Oxygen consumption was continuously recorded during the exercise phases using the gas analyzer, while the total step count for each stage was captured using a video camera.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obese Young Adults
This study includes 48 obese young adults, approximately 20 years old, with 28 males and 20 females.
treadmill walking
all participants walking at increasing speeds on a treadmill
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
treadmill walking
all participants walking at increasing speeds on a treadmill
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI classified as obese (≥27 kg/m²)
* Able to walk on a treadmill without assistance
Exclusion Criteria
* History of bariatric surgery
* Current participation in structured exercise program
19 Years
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese Culture University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
TSUNG-LIN CHIANG
Researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chinese Culture University
Taipei, Taiwan, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chiang TL, Lin YC, Chen C, Chan SH, Ye YY, Hsu CH, Su PW, Wu HJ. Individualized walking cadence thresholds of moderate to vigorous intensity for Taiwanese obese young adults. BMC Public Health. 2025 Oct 14;25(1):3471. doi: 10.1186/s12889-025-24805-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
105-2815-C-034-028-H
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
No. 105-2815-C-034-028-H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.